Effective: 2023-08-01

Course Description

The course outline below was developed as part of a statewide standardization process.

General Course Purpose

The purpose of this course is to introduce the competent learner to concepts of nursing practice across the lifespan.

Course Prerequisites/Corequisites

Prerequisites: BIO 150 (or BIO 205), NSG 152 and NSG 170

Course Objectives

• Apply principles of patient-centered care across the lifespan.
• Incorporate factors for improvement in client safety for clients across the lifespan.
• Apply clinical judgment when prioritizing the delivery of client-centered care for clients with multiple needs and in various clinical settings.
• Incorporate legalethical principles and professional nursing standards in the care of clients.
• Examine the impact of quality improvement processes, information technology and fiscal resources in the provision of nursing care.
• Participate as a member of the health care team in the delivery of nursing care across the lifespan.
• Integrate the principles of pharmacology to the identified concepts for all client populations across the lifespan.
• Integrate pathophysiology and principles of pharmacology in the delivery of client care in a variety of populations.

Major Topics to be Included

• Mood and Affect Concept:
• Mood and affect principles
• Risk factors related to altered mood and affect
• Prevention of altered mood and affect
• Clinical judgment related to mood and affect
• Pharmacology: Monoamine Oxidase Inhibitors (MAOI), Selective Serotonin Reuptake Inhibitors (SSRI), Selective Norepinephrine Reuptake Inhibitors (SNRI), Tricyclic Antidepressants, Norepinephrine and Dopamine Reuptake, Inhibitors (Bupropion), Lithium; Anticonvulsants: Valprioc acid, Divalproex, Carbamazepine, Gabapentin, Lamotrigine;
• Exemplars: depression, postpartum depression, bipolar disorder, suicide
• Psychosis Concept:
• Psychosis principles
• Risk factors related to psychosis
• Prevention of psychosis
• Clinical judgment related to psychosis
• Pharmacology: 1st generation antipsychotics- dopamine receptor antagonists (DRA): Adasuve, fluphenazine, Haldol Decanoate, haloperidol, loxapine, loxapine inhaled; 2nd generation antipsychotics-serotonin-dopamine antagonists: asenapine, clozapine, iloperidone, lumateperone, lurasidone, olanzapine, paliperidone, quetiapine; 3rd generation antipsychotics-partial dopamine D2 agonist: Aripiprazole, Cariprazine, Brexipiprazole, Lumateperone; Anticholinergics (Benztropine, diphenhydramine)
• Exemplar: schizophrenia
• Anxiety Concept:
• Fight or flight response
• Risk factors related to anxiety
• Prevention strategies related to anxiety
• Clinical judgment related to anxiety
• Pharmacology: Benzodiazepines, Anxiolytics (Buspirone, Hydroxyzine)
• Exemplars: generalized anxiety disorder, phobias, Obsessive Compulsive Disorder (OCD), panic disorders, Post-Traumatic Stress Disorder (PTSD)
• Cognition Concept:
• Cognition principles
• Risk factors related to cognitive alterations
• Prevention of cognitive alterations
• Cognitive diagnostic testing
• Clinical judgment related to cognitive alterations
• Pharmacology: Atypical antipsychotic-2nd generation (Risperidone, aripiprazole), Acetylcholinesterase inhibitor (Galantamine), Cholinesterase Inhibitor (Rivastigmine, donepezil), Central nervous system stimulants (Dextroamphetamine, Methylphenidate, Amphetamine)
• Exemplars: developmental delay: spectrum disorders
• Attention-Deficit/Hyperactive Disorder (ADHD), delirium, Alzheimer?s disease/dementia
• Violence Concept:
• Violence principles
• Risk factors related to violence
• Prevention of violence
• Clinical judgment related to violence
• Recognize, intervene, and report abuse
• Exemplars: child abuse, elder abuse, intimate partner violence
• Sensory Perception Concept:
• Sensory perception principles
• Risk factors related to sensory alterations
• Prevention of sensory alterations
• Sensory diagnostic testing
• Clinical judgment related to sensory alterations
• Pharmacology: Prostaglandin analogs (latanoprost), Alpha Adrenergic agonists (apraclonidine), Carbonic anhydrase inhibitors (acetazolamide), Gabapentin, Tricyclic antidepressants, Topical anesthetic agents, Cholinergic (pilocarpine), Beta-Blockers (timolol maleate)
• Exemplars: cataracts, glaucoma, hearing loss, peripheral neuropathy
• Immunity Concept:
• Immunity principles
• Risk factors related to altered immunity
• Prevention of altered immunity
• Immunity diagnostic testing
• Clinical judgment related to altered immunity
• Pharmacology: Antiretroviral therapy: Nucleoside Reverse Transcriptase Inhibitors (NRTIs), Non-Nucleoside Reverse Transcriptase Inhibitors, Protease Inhibitors, Integrase Strand Transfer Inhibitors, Fusion Inhibitor, CCR5 Antagonist, CD4 Post-Attachment Inhibitor; PreP, Antihistamines (diphenhydramine); Antirejection medications for organ transplant: Corticosteroids (prednisone), Calcineurin inhibitors (tacrolimus, cyclosporine), Antiproliferative agents (mycophenolate mofetil, azathioprine, or sirolimus); Epinephrine
• Exemplars: Human Immunodeficiency Virus Infection and Acquired Immune Deficiency Syndrome (HIV/AIDS), anaphylaxis, systemic lupus erythematosus, organ transplant
• Inflammation Concept:
• Inflammation principles
• Risk factors related to inflammation
• Prevention of inflammation
• Inflammation diagnostic testing
• Clinical judgment related to inflammation
• Pharmacology: Antacids, Proton Pump Inhibitors, Anti-inflammatory medications, H2-receptor antagonists, Sulfa-free aminosalicylates (mesalamine), Immunomodulators (azathioprine, mercaptopurine, methotrexate, cyclosporine), Anti-tumor necrosis factor (TNF) medications (adalimumab), Disease-modifying antirheumatic drugs (DMARDs)
• Exemplars: acute inflammation, inflammatory bowel disease, gastroesophageal reflux disease, rheumatoid arthritis